Trials / Completed
CompletedNCT01255904
A Trial Of Oral Chloral Hydrate Versus Intranasal Dexmedetomidine For Sedated Abr Exams
A RANDOMIZED CONTROLLED TRIAL OF ORAL CHLORAL HYDRATE VERSUS INTRANASAL DEXMEDETOMIDINE FOR SEDATED ABR EXAMS.
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 90 (actual)
- Sponsor
- Baylor College of Medicine · Academic / Other
- Sex
- All
- Age
- 6 Months – 8 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to compare the efficacy of oral chloral hydrate to intranasal dexmedetomidine for the successful completion of a sedated ABR exam (hearing exam).
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Chloral Hydrate | Oral chloral hydrate 50 mg/kg |
| DRUG | Dexmedetomidine | Intranasal dexmedetomidine 3 mcg/kg |
| OTHER | Oral placebo | Oral saline administered |
| OTHER | Intranasal placebo | Intranasal saline administered |
Timeline
- Start date
- 2011-08-01
- Primary completion
- 2014-11-01
- Completion
- 2014-11-01
- First posted
- 2010-12-08
- Last updated
- 2016-05-16
- Results posted
- 2016-02-22
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT01255904. Inclusion in this directory is not an endorsement.